Kelly Financial Services LLC Anavex Life Sciences Corp. Transaction History

Kelly Financial Services LLC

  • $258 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Jul 17, 2024
SELL
$16.82 - $25.75 $1.47 Million - $2.25 Million
-87,440 Reduced 95.63%
4,000 $71.8 Million
Q2 2021

Jul 17, 2024
BUY
$10.16 - $28.86 $898,550 - $2.55 Million
88,440 Added 2948.0%
91,440 $4 Million
Q1 2021

Jul 17, 2024
BUY
$5.17 - $16.13 $14,476 - $45,164
2,800 Added 1400.0%
3,000 $44.9 Million
Q4 2020

Jul 17, 2024
BUY
$4.01 - $7.58 $802 - $1,516
200 New
200 $1.08 Million

Others Institutions Holding AVXL

# of Institutions
157
Shares Held
26.6M
Call Options Held
673K
Put Options Held
811K
View Full List

About ANAVEX LIFE SCIENCES CORP.

AVXL Quotes by TradingView
  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $720M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track Kelly Financial Services LLC Portfolio

Follow Kelly Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kelly Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kelly Financial Services LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email